Jiangsu, China

Cheng Li

USPTO Granted Patents = 5 


Average Co-Inventor Count = 9.2

ph-index = 1


Location History:

  • Jiangsu, CN (2020 - 2021)
  • Nanjing, CN (2023)

Company Filing History:


Years Active: 2020-2025

where 'Filed Patents' based on already Granted Patents

5 patents (USPTO):

Title: Innovations and Contributions of Inventor Cheng Li

Introduction

Cheng Li is a notable inventor based in Jiangsu, China, recognized for his significant contributions to the field of pharmaceuticals and technology. With a total of five patents to his name, he has made strides in developing innovative solutions that address complex challenges in the industry.

Latest Patents

One of Cheng Li's latest patents is the "Pro-insulin aspart structure and method for preparing insulin aspart." This invention provides a novel pro-insulin aspart structure design and a method for its preparation. The method involves designing the pro-insulin aspart sequence, constructing recombinant insulin aspart engineered bacteria, and inducing the expression of an insulin fusion protein as an inclusion body in the engineered bacteria. The extraction process of the insulin fusion protein includes denaturing, renaturing enzymatic digestion, and separation purification operations. By modifying the recombinant leading peptide and C-peptide sequences, this method eliminates the need for a cyanogen bromide cleavage step, enhancing the overall efficiency of the process. Additionally, the C-peptide can be replaced by a single amino acid, which helps reduce quality loss associated with enzymatic digestion.

Another significant patent is the "Trace chain information query method and device." This application outlines a method for querying trace chain information, which includes receiving first and second trace chain information from different service nodes triggered by the same user operation. The trace chain server identifies and finds the relevant information based on a group identifier, facilitating efficient data management and retrieval.

Career Highlights

Cheng Li has worked with prominent companies, including Amphastar Nanjing Pharmaceuticals Inc. and State Grid Jiangsu Electric Power Company. His experience in these organizations has allowed him to apply his innovative ideas and contribute to advancements in the pharmaceutical and energy sectors.

Collaborations

Cheng Li has collaborated with notable colleagues, including Chuangen Tang and Shangshu Pan. Their combined expertise has fostered a productive environment for innovation and development.

Conclusion

Cheng Li's work exemplifies the spirit of innovation and dedication to improving technology and healthcare. His patents reflect a commitment to advancing scientific knowledge and practical applications in his field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…